From: Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon
Variables | Absence of C. difficile n (%) / mean | Presence of C. difficile n (%) / mean | Brute OR | 95% CI | P-value |
---|---|---|---|---|---|
Age | |||||
Age ± SD | 33.72 ± 2.3 | 30.12 ± 3.7 | 0.99 | 0.97–1.00 | 0.11 |
Sex | |||||
Female | 104 (71.7) | 41 (28.3) | 1 | ||
Male | 114 (73.5) | 41 (26.4) | 0.91 | 0.55–1.52 | 0,72 |
Hospital | |||||
CHUY | 72 (75.0) | 24 (25.0) | 1 | ||
HCY | 50 (67.6) | 24 (32.4) | 1.44 | 0.74–2.82 | 0.29 |
HM | 35 (66.0) | 18 (33.9) | 0.89 | 0.74–3.21 | 0.25 |
HP | 34 (80.9) | 8 (19.0) | 1.54 | 0.29–1.73 | 0.45 |
HE | 27 (77.1) | 8 (22.8) | 0.71 | 0.36–2.22 | 0.80 |
Hospitalization | |||||
Not | 88 (81.5) | 20 (18.5) | 1 | ||
Yes | 130 (67.7) | 62 (32.2) | 2.10 | 1.18–3.72 | 0,01 |
HIV | |||||
Not | 139 (70.9) | 57 (29.0) | 1 | ||
Yes | 79 (75.9) | 25 (24,0) | 0.77 | 0.4–1.33 | 0.35 |
Use of penicilline | |||||
Not | 204 (72.6) | 77 (27.4) | 1 | ||
Yes | 14 (73.7) | 5 (26.3) | 0.95 | 0.33–2.72 | 0.92 |
Use of cephalosporine | |||||
Not | 209 (72.6) | 79 (27.4) | 1 | ||
Yes | 9 (75.0) | 3 (25.0) | 0.88 | 0.23–3.34 | 0.85 |
Use of imidazole | |||||
Not | 203 (72.5) | 77 (27.5) | 1 | ||
Yes | 15 (75.0) | 5 (25.0) | 0.88 | 0.31–2.5 | 0.81 |
Use of aminoside | |||||
Not | 216 (72.9) | 80 (27.0) | 1 | ||
Yes | 2 (50.0) | 2 (50.0) | 2.7 | 0.37–19.5 | 0.33 |
Use of vancomycine | |||||
Not | 216 (73.2) | 79 (26.8) | 1 | ||
Yes | 2 (40.0) | 3 (60.0) | 4.10 | 0.67–27.0 | 0.13 |
Use of quinolone | |||||
Not | 209 (72.3) | 80 (27.7) | 1 | ||
Yes | 9 (81.8) | 2 (18.2) | 0.58 | 0.12–2.75 | 0.49 |
Use of corticoids | |||||
Not | 214 (72.8) | 80 (27.2) | 1 | ||
Yes | 4 (66.66) | 2 (0.3) | 1.34 | 0.24–7.45 | 0.74 |